Thomas Bock

Thomas Bock

Corporate Officer/Principal bei
American Society of Hematology
62 Jahre
Health Technology
Commercial Services
Consumer Services

Profil

Thomas A. Bock is the founder of Heritx, Inc. Current jobs include Member at American Society of Clinical Oncology, Inc. and Member at American Society of Hematology.
Former jobs include Chief Executive Officer & Secretary at Notable Labs, Inc. from 2020 to 2024; President, Chief Executive Officer & Director at Notable Labs Ltd. from 2023 to 2024; Medical Director-Hematology & Oncology Program at Amgen (Europe) GmbH; Vice President & Global Head-Medical Affairs at Celgene Corp.
from 2007 to 2010; Senior Vice President-Global Medical Affairs at Alexion Pharmaceuticals, Inc. from 2010 to 2013; Vice President & Head-Global Medical Affairs at Novartis Oncology, Inc.; Member at Rotary International, Inc.; and Member at American Society of Nephrology.
Education includes an MBA from The Trustees of Columbia University in The City of New York and a doctorate from RWTH Aachen University.

Aktive Positionen von Thomas Bock

UnternehmenPositionBeginn
Corporate Officer/Principal -
Corporate Officer/Principal -

Ehemalige bekannte Positionen von Thomas Bock

UnternehmenPositionEnde
Vorstandsvorsitzender 01.08.2024
ALEXION PHARMACEUTICALS, INC. Technik-/Wissenschafts-/F&E-Leiter 01.09.2013
CELGENE Technik-/Wissenschafts-/F&E-Leiter 01.01.2010
Vorstandsvorsitzender -
Sehen Sie sich die Erfahrung von Thomas Bock im Detail an

Ausbildung von Thomas Bock

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

79

Beziehungen ersten Grades

12

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen12

Health Technology

Health Technology

Health Technology

Consumer Services

Commercial Services

Consumer Services

Health Services

Commercial Services

Health Services

Health Technology

Health Technology

Commercial Services

  1. Börse
  2. Insiders
  3. Thomas Bock